The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,N'-(Disulfanediylbis(ethane-2,1-diyl))bis(5-(3-bromo-4-hydroxyphenyl)-1H-pyrazole-3-carboxamide) ID: ALA4557651
PubChem CID: 155554796
Max Phase: Preclinical
Molecular Formula: C24H22Br2N6O4S2
Molecular Weight: 682.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCSSCCNC(=O)c1cc(-c2ccc(O)c(Br)c2)[nH]n1)c1cc(-c2ccc(O)c(Br)c2)[nH]n1
Standard InChI: InChI=1S/C24H22Br2N6O4S2/c25-15-9-13(1-3-21(15)33)17-11-19(31-29-17)23(35)27-5-7-37-38-8-6-28-24(36)20-12-18(30-32-20)14-2-4-22(34)16(26)10-14/h1-4,9-12,33-34H,5-8H2,(H,27,35)(H,28,36)(H,29,31)(H,30,32)
Standard InChI Key: CFJXFDRZXMULEW-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
4.8292 -6.0509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2345 -5.7591 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.0848 -5.7466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5461 -5.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1181 -5.8401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0916 -5.3556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5543 -5.1442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2996 -5.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8613 -6.5867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8032 -5.7591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3707 -5.1737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3734 -5.3347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5973 -5.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8838 -4.5178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6876 -4.3513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0932 -6.5706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7964 -5.3347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0997 -5.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6459 -6.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6618 -5.7466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5147 -5.3472 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.4302 -6.7655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3445 -4.3911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9461 -5.3431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0575 -6.7574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6644 -4.5359 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4162 -5.3433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3801 -5.7675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1904 -6.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9528 -5.7717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6126 -6.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9189 -5.0899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1989 -5.4329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6644 -5.3597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3716 -6.0763 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1617 -4.4151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2123 -7.4878 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
18.5018 -6.5616 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
32 8 2 0
1 27 2 0
17 3 1 0
18 15 1 0
2 21 1 0
6 28 1 0
5 7 2 0
4 18 2 0
3 12 1 0
19 1 1 0
8 5 1 0
14 17 2 0
9 30 2 0
29 31 1 0
12 20 1 0
25 9 1 0
31 22 2 0
17 4 1 0
24 2 1 0
29 35 1 0
26 34 2 0
7 11 1 0
27 13 1 0
30 33 1 0
22 1 1 0
18 32 1 0
36 23 2 0
33 19 2 0
15 14 1 0
16 3 2 0
21 10 1 0
20 24 1 0
10 6 1 0
19 25 1 0
7 36 1 0
23 32 1 0
34 30 1 0
28 34 1 0
13 29 2 0
31 37 1 0
5 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 682.42Molecular Weight (Monoisotopic): 679.9511AlogP: 4.94#Rotatable Bonds: 11Polar Surface Area: 156.02Molecular Species: NEUTRALHBA: 8HBD: 6#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 7.67CX Basic pKa: 0.92CX LogP: 4.04CX LogD: 3.83Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.10Np Likeness Score: -0.55
References 1. Wen J, Bao Y, Niu Q, Liu J, Yang J, Wang W, Jiang T, Fan Y, Li K, Wang J, Zhao L, Liu D.. (2016) Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents., 26 (17): [PMID:27460171 ] [10.1016/j.bmcl.2015.12.094 ]